Protocol for tissue slice cultures from human solid tumors to study therapeutic response
暂无分享，去创建一个
[1] L. Hood,et al. Modulation of Immune Checkpoints by Chemotherapy in Human Colorectal Liver Metastases , 2020, Cell reports. Medicine.
[2] E. Holland,et al. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses , 2020, Journal for ImmunoTherapy of Cancer.
[3] R. Yeung,et al. Human Liver Macrophage Subsets Defined by CD32 , 2020, Frontiers in Immunology.
[4] C. Lausted,et al. Tumor slice culture as a biologic surrogate of human cancer. , 2020, Annals of translational medicine.
[5] O. Elemento,et al. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery , 2019, Oncoimmunology.
[6] Helen Horton,et al. Precision-cut human liver slice cultures as an immunological platform. , 2018, Journal of immunological methods.
[7] Sheng Pan,et al. Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment , 2017, Oncoimmunology.
[8] C. Crane,et al. Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy. , 2017, Human gene therapy.
[9] W. Leeman,et al. Cytotoxicity of retinoic acid, menadione and aflatoxin B(1) in rat liver slices using Netwell inserts as a new culture system. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.
[10] K. Rajagopalan,et al. from Human Liver , 1976 .